arrow
N

Nicole Gormley

us food & drug administration (fda)
H指数:24
被引数:1,892

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials

美国食品药品监督管理局对一线晚期免疫肿瘤学肾细胞癌试验中根据缓解深度进行的总生存期合并分析

2025-08-010
OAAI
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

关于多发性骨髓瘤先兆临床试验优化设计的圆桌讨论

2024-05-012
OA
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development
2023-12-121
PRE
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
2022-07-015
OAAI
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
2021-10-013
OAAI
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
2021-07-283
OAAI
The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology
2021-04-280
OA